
Global Wellness Pharma Subsidiary Supports Cancer Therapeutic Company AVM Biotechnology
Vancouver, British Columbia, December 05, 2022 – Global Wellness Strategies Inc. (CSE: GWS) (Frankfurt: O3X4) (OTCQB: GWSFF) (“Global Wellness” or the “Company”) pharma subsidiary is